![]() insulinK: World's First Insulin Dosage TrackerConnecting Blood Glucose Levels and Insulin Dosages Automatically
By: Beijing Dnurse technology Co.,Ltd. Beijing Dnurse Technology Ltd, the inventors of insulinKTM, was founded in July 2013. They are the first innovative Chinese mobile medical company focused on diabetes management. Dnurse has successfully built their "Device + App + Service" business model through advanced Smartphone Blood Glucose Meters, Smart Apps, and cloud database storage. With the use of mobile Internet technology, Dnurse provides reliable tools, helping regulate the habits of Diabetics, managing blood glucose with precision, reducing complications, and subsequent medical costs. insulinKTM, the world's first insulin dosage tracker, auto-records insulin dosages, links several key factors and also helps users understand the relationship between all aspects. It is a breakthrough, filling in the missing link between insulin dosages and blood glucose levels. With insulinKTM, Diabetics will have a clearer grasp of their diabetes and can, in turn, manage it better. It is a really helpful tool because insulin dosage records are important to Diabetics and also highly useful to Doctors. With constant and precise records, Doctors can prescribe medicine and adjust dosage levels more accurately. InsulinKTM not only helps Users understand the intersection of insulin dosages and blood glucose levels but also strengthens the App's IDSS (Intelligent Decision Supporting System) accuracy. The appearance of insulinKTM makes the Dnurse App the world's first product to record and track blood glucose levels, insulin dosages, medication, dietary intake, and physical activity data, all the while giving Personalized feedback and recommendations. Dnurse has been committed to improving Diabetics' self-management ability through mobile Internet tools and devices, thereby decreasing the incremental cost of hospital medical resources. Dnurse, in their efforts to look ahead of trends, wants a limited resource, such as Doctors, to be utilized more efficiently. The release of IDSS, Dnurse Xing, and insulinKTM seems to suggest the lack of medical resources for Diabetics in China. Under such conditions, Dnurse didn't focus on the use of existing medical resources. Adhering to "science and technology can change diabetes management", they achieved low costs and high efficiency even outside hospitals. The vision of Dnurse is also to provide assistance to insurance companies and health management agencies to help reduce the cost of controlling the occurrence of Diabetic complications. Media Contact Navin Mohanan HeyDepot service@heydepot.com +1-678-670-0621 Photos: https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ End
|